You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR DEXMETHYLPHENIDATE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for dexmethylphenidate hydrochloride

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00047476 ↗	D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients	Completed	Celgene Corporation	Phase 2	2002-06-01	To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects.
NCT00141050 ↗	Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD	Completed	Novartis	Phase 3	2005-05-01	The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
NCT00141063 ↗	Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD	Completed	Novartis	Phase 3	2005-06-01	The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
NCT00301236 ↗	Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder	Completed	Novartis	Phase 3	2006-02-01	The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for dexmethylphenidate hydrochloride

Condition Name

Chart
Table

Condition Name for dexmethylphenidate hydrochloride
Intervention	Trials
ADHD	5
Attention Deficit Hyperactivity Disorder	3
Sarcoidosis	2
Attention Deficit Hyperactivity Disorder Combined	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for dexmethylphenidate hydrochloride
Intervention	Trials
Attention Deficit Disorder with Hyperactivity	7
Hyperkinesis	4
Fatigue	3
Sarcoidosis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for dexmethylphenidate hydrochloride

Trials by Country

Map
Table

Trials by Country for dexmethylphenidate hydrochloride
Location	Trials
United States	57
United Kingdom	1
Brazil	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for dexmethylphenidate hydrochloride
Location	Trials
Kansas	4
Georgia	3
Florida	3
California	3
Arizona	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for dexmethylphenidate hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for dexmethylphenidate hydrochloride
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	6
Phase 2	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for dexmethylphenidate hydrochloride
Clinical Trial Phase	Trials
Completed	11
Not yet recruiting	4
Recruiting	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for dexmethylphenidate hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for dexmethylphenidate hydrochloride
Sponsor	Trials
Cingulate Therapeutics	4
Novartis	4
Corium, Inc.	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for dexmethylphenidate hydrochloride
Sponsor	Trials
Industry	18
Other	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.